UMC
Welcome,         Profile    Billing    Logout  
 5 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Erpecum, Karel v
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
Sommer, Iris
PRECISER, NCT05768126: Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine

Recruiting
4
100
Europe
Rivastigmine Transdermal Product, Sham
UMC Utrecht, ZonMw: The Netherlands Organisation for Health Research and Development, St. Antonius Hospital, Tergooi Hospital
Depressive Disorder
12/25
01/26
Oostergo, Tanja
SIRIUS, NCT05375708: Systemic Therapy in Combination With Stereotactic Radiotherapy in Patients With Metastatic Colorectal Cancer up to 10 Metastatic Sites

Not yet recruiting
2
93
Europe
Stereotactic body radiation therapy (SBRT), Maintenance therapy (CAP-B or 5-FU/LV plus bevacizumab.)
UMC Utrecht
Metastatic Colorectal Cancer, Oligometastatic Disease
06/28
06/28
NCT06659926: The Radium-select Study

Not yet recruiting
N/A
60
Europe
68Ga-PSMA-PET/CT scan, Online patient reported outcome measure (PROM) questionnaires, Blood sampling
The Netherlands Cancer Institute, Bayer
mCRPC, Male Urogenital Diseases
07/29
07/29

Download Options